跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,659 条关于
“Beijing Hanmi Pharmaceutical”
全部
15,659
临床试验
2,373
药物
1,983
机构
2,254
资讯
9,049
去年
Hanmi's BH3120 Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Hanmi Pharmaceutical Advances BH3120 Immunotherapy Trials Targeting Solid Tumors
去年
Hanmi's BH3120 Shows Promise in Phase 1 Trials for Advanced Solid Tumors
12天前
Hanmi Pharmaceutical to Fully Deploy AI Across Quality Assurance, Training on 4,000 SOPs
去年
Hanmi Pharmaceutical Fast-Tracks Efeglenatide Launch for Obesity Treatment
去年
Hanmi Pharmaceutical to Present Phase 1 Results of Next-Generation Obesity Drugs at ADA 2025
2年前
Hanmi Pharmaceutical Partners with MSD to Test Novel Bispecific Antibody BH3120 in Combination with KEYTRUDA
2年前
GC Biopharma and Hanmi Pharmaceutical's Fabry Disease Treatment LA-GLA Receives FDA IND Clearance
去年
Hanmi Pharmaceutical Advances Six New Drugs into Clinical Trials Targeting Hypertension, Diabetes, and Cancer
9个月前
Hanmi Pharmaceutical's Efeglenatide Receives Fast Track Designation for Obesity Treatment in South Korea
第 1 页，共 905 页
上一页
下一页
